-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
April 08, 2014 - Text Description . … Text Description . … Text Description . … Text Description . … Text Description .
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary12/bacterial-vaginosis-in-pregnancy-to-prevent-preterm-delivery-screening-february-2008
February 15, 2008 - It is not clear from the detailed description of the studies which factors explain the differences in … The detailed description of these studies do not clearly indicate which factors may explain the differences … Study characteristics and absolute risk reduction of delivery before 37 weeks (Text Description) … Absolute risk reduction of delivery before 34 weeks and before 32 weeks (Text Description)
Study … 0/1
Was there a description of withdrawals and dropouts?
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan88/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
February 18, 2014 - Analytic Framework
Text Description .
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan108/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
October 16, 2014 - Framework
Text Description
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan99/celiac-disease-screening
November 03, 2014 - Text Description .
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan144/thyroid-cancer-screening
April 23, 2015 - Analytic Framework
Text Description
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan137/gynecological-conditions-screening-with-the-pelvic-examination
March 05, 2015 - Analytic Framework
Text Description
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan108/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
October 16, 2014 - Framework
Text Description
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan88/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions-september-2015
February 18, 2014 - Framework
Text Description
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan95/syphilis-infection-in-nonpregnant-adults-and-adolescents-june-2016
September 18, 2014 - Analytic Framework
Text Description
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/skin-cancer-counseling
June 30, 2016 - Analytic Framework
Text Description
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ykFSVS29KAwKzFWSXAVoMY
June 01, 2009 - Preventive Services Task Force*
Description: Reaffirmation of the 2004 U.S. … Preventive Services Task Force Levels of Certainty Regarding Net Benefit
Level of Certainty* Description
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/xw8Xj4Bts4yaj_ZaBjCuer
May 01, 2009 - Preventive Services Task Force*
Description: Update of the 2004 U.S. … Preventive Services Task Force Levels of Certainty Regarding Net Benefit
Level of
Certainty*
Description
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/hWPZYvUZJXUQghbFtSDC42
August 01, 2011 - Preventive Services Task Force*
Description: Update of the 2004 U.S. … USPSTF Levels of Certainty Regarding Net Benefit
Level of
Certainty*
Description
High The available … Specifically, input from clinical specialists led to
changes in the description of treatments.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/_xHkw4GBnFbY3eWncxmZDA
January 01, 2004 - Description and Results of Randomized Trials of Thyroxine Replacement Therapy*
Anti-TG, anti-thyroglobulin … 6/31 Quality of Chronic Thyroid No improvement in Placebo group’s Only 1 case of atrial Fair Fair Description … Description and Results of Randomized Trials of Thyroxine Replacement Therapy* (cont)
continue
14 … Description and Results of Randomized Trials of Thyroxine Replacement Therapy* (cont)
15
Screening … Description and Results of Randomized Trials of Thyroxine Replacement Therapy* (cont)
16
Screening
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/sexually-transmitted-infections-behavioral-counseling
August 18, 2020 - Source
Study quality
Country, recruitment setting
No. randomized, population description … Intervention name (description)
Mean age (range), y
Female, %
Race/ethnicity, %
Sexual … Intervention name (description)
Mean age (range), y
Female, %
Race/ethnicity, %
Sexual … Intervention name (description)
Mean age (range), y
Female, %
Race/ethnicity, %
Sexual … Intervention name (description)
Mean age (range), y
Female, %
Race/ethnicity, %
Sexual
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary49/thyroid-disease-screening-2004
January 15, 2004 - Description and Results of Randomized Trials of Thyroxine Replacement Therapy a :
Study, Year … Description and Results of Randomized Trials of Thyroxine Replacement Therapy a
Study, Year
Patients … through dropouts
1 case of atrial fibrillation and 1 case of angina in LT4 group
Fair
Fair
Description … Description and Results of Randomized Trials of Thyroxine Replacement Therapy a
Study, Year
Patients … in 50-mg group
LDLc reduction was significant in 50-mg group
No
Not assessed
Poor
Fair
Description
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-supplemental-screening-in-women-with-dense-/breast-cancer-screening-january-2016
January 11, 2016 - Text Description . … Text Description . … Text Description . … Text Description . … Text Description .
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-risk-screening-with-electrocardiography
July 14, 2016 - Text Description .
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan138/breastfeeding-primary-care-interventions
December 18, 2014 - Analytic Framework
Text Description